Bovine Pericardial Valve Market Growth To $2.53 Billion Creates New Opportunities Across The Industry
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Bovine Pericardial Valve Market Value Growth And Long-Term Outlook
The market size for bovine pericardial valves has demonstrated significant expansion over recent years. Forecasts indicate it will expand from $1.57 billion in 2025 to $1.72 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.9%. This historical expansion can be linked to several factors: a growing incidence of valvular heart conditions among the elderly population, a greater uptake of open-heart surgical valve replacement operations, improvements in cardiac surgery methods and perioperative care, the wider availability of bioprosthetic valve choices in healthcare facilities, and heightened public understanding of cardiovascular disease treatments.
The bovine pericardial valve market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $2. 53 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10. 1%. This predicted growth throughout the forecast period stems from several factors, including a heightened demand for minimally invasive and transcatheter procedures, an expanding global elderly population necessitating valve replacements, ongoing progress in tissue engineering and biomaterial innovation, an increasing preference for long-lasting valve options requiring minimal anticoagulation, and the development of healthcare infrastructure and cardiac care access in emerging regions. Key trends shaping the forecast period involve a greater uptake of advanced bioprosthetic heart valve materials designed for improved durability, an escalating requirement for minimally invasive valve replacement operations, a heightened emphasis on anti-calcification treatment technologies for tissue valves, the wider implementation of transcatheter heart valve implantation procedures, and a growing clinical inclination towards durable biologic valve substitutes instead of mechanical ones.
Get A Free Sample Report With In-Depth Market Insights:
Bovine Pericardial Valve Market Demand Drivers: What’s Powering Industry Growth?
The increasing occurrence of cardiovascular diseases is projected to boost the expansion of the bovine pericardial valve market in the future. These conditions, known as CVDs, encompass various heart and blood vessel disorders such as coronary artery disease, ischemic heart disease, heart failure, and valvular issues, and continue to be the primary cause of sickness and death globally. The growing incidence of CVDs is primarily attributed to more sedentary lifestyles, as decreased physical activity can slow metabolism and lead to obesity, significantly increasing the likelihood of heart-related ailments. Bovine pericardial valves assist in managing cardiovascular diseases by offering a resilient and body-compatible option for surgical valve replacement in individuals with CVDs, particularly when valvular heart disease necessitates sustained function and a lower chance of repeat surgery. For example, as reported by the American College of Cardiology, a US-based medical association, in September 2025, the number of cardiovascular disease fatalities globally climbed to 19. 2 million in 2023, an increase from 2022. Consequently, the rising prevalence of cardiovascular diseases is a key factor driving the growth of the bovine pericardial valve market.
Bovine Pericardial Valve Market Segmentation: How Does The Market Break Down By Category?
The bovine pericardial valve market covered in this report is segmented –
1) By Product Type: Surgical Valves, Transcatheter Valves
2) By Age Group: Pediatric, Adult
3) By Application: Aortic Valve Replacement, Mitral Valve Replacement, Tricuspid Valve Replacement
4) By End User: Hospitals, Cardiac Centers, Ambulatory Surgical Centers
Subsegments:
1) By Surgical Valves: Aortic Valve, Mitral Valve, Tricuspid Valve, Pulmonary Valve
2) By Transcatheter Valves: Transcatheter Aortic Valve, Transcatheter Mitral Valve, Transcatheter Pulmonary Valve, Transcatheter Tricuspid Valve
Bovine Pericardial Valve Market Innovation Trends: What Developments Are Reshaping The Industry?
Companies active in the bovine pericardial valve market are concentrating on creating sophisticated products, such as next-generation surgical aortic tissue valves, to improve procedural efficiency and long-term patient results. A next-generation surgical aortic tissue valve is a sophisticated bioprosthetic valve engineered to substitute a diseased aortic valve with enhanced durability and performance. It boosts blood flow efficiency and minimizes complications, thereby supporting superior patient outcomes. For instance, in April 2024, Medtronic, an Ireland-based medical technology company, unveiled the Avalus Ultra Valve, a next-generation surgical aortic tissue valve crafted to make implantation easier and facilitate lifelong patient management. The Avalus Ultra Valve incorporates advanced tissue treatment for better durability, an optimized leaflet design for improved hemodynamic performance, and user-friendly handling characteristics that simplify surgical procedures, contributing to consistent clinical outcomes and reliable long-term valve function.
Bovine Pericardial Valve Market Company Landscape And Competitive Strategy
Major companies operating in the bovine pericardial valve market are Shanghai Cingular Biotechnology Co Ltd, Medtronic plc, Edwards Lifesciences Corporation, Meril Life Sciences Pvt Ltd, Lepu Medical Technology Beijing Co Ltd, MicroPort Scientific Corporation, Braile Biomédica Indústria Comércio e Representações SA, Venus Medtech Hangzhou Inc, Peijia Medical Limited, Artivion Inc, Balance Medical Limited, HighLife SAS, Maverick Biosciences Inc
View The Full Bovine Pericardial Valve Market Report:
Bovine Pericardial Valve Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the bovine pericardial valve market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bovine pericardial valve market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
